The Guardian
Email YouTube Facebook Instagram Twitter
 
News : Business

Biotech in China is just getting started, says Loncar Investments’s CEO

By Bloomberg
02 Apr 2019   |   11:40 am   |   2m 59s
Brad Loncar, chief executive officer at Loncar Investments, discusses investing in China’s biotech sector and which companies he likes.


Share:

You may also like

U.S 30-year treasury yield hit record low, backs fears of global recession
2 days ago  Business
How global trade tensions are impacting Ghana’s economy
2 days ago  Business
Nigeria’s intervention in protecting Nigerian nationals in diaspora
3 days ago  Business
Devakumar: Dangote refinery ready to start by end of 2020
3 days ago  Business
Nigeria’s July inflation slows to 11.08%: A look at the markets
2 days ago  Business
Equity markets declining as oil prices look likely to suffer as well: A closer look at the markets
3 days ago  Business
KOBO360 raises $30mn funding: What challenges are Nigeria facing?
3 days ago  Business
IEA: Oil demand increases due to U.S-China trade war: How is this affecting Nigeria?
3 days ago  Business
Signs of life in London’s housing market
1 day ago  Business